Back to Search
Start Over
Importance of adherence to BCR-ABL tyrosine-kinase inhibitors in the treatment of chronic myeloid leukemia
- Source :
- Revista Brasileira de Hematologia e Hemoterapia v.36 n.1 2014, Revista brasileira de hematologia e hemoterapia, Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular (ABHHTC), instacron:ABHHTC, Revista Brasileira de Hematologia e Hemoterapia, Vol 36, Iss 1, Pp 54-59 (2014), Revista Brasileira de Hematologia e Hemoterapia, Revista Brasileira de Hematologia e Hemoterapia, Volume: 36, Issue: 1, Pages: 54-59, Published: JAN 2014
- Publication Year :
- 2014
- Publisher :
- Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular, 2014.
-
Abstract
- Treatment of chronic myeloid leukemia with BCR-ABL tyrosine kinase inhibitors requires full adherence in order to maximize the likelihood of achieving optimal responses, and to minimize healthcare costs. In this article, we review some of the methods available for assessing compliance, the main consequences of nonadherence on treatment outcomes, major factors commonly associated with poor compliance, a few successful measures for improving adherence and the most accepted recommendations for proactively managing adverse events.© 2014 Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Editora Ltda. All rights reserved.
- Subjects :
- Oncology
medicine.medical_specialty
BCR-ABL positive
business.industry
Poor compliance
lcsh:RC633-647.5
Treatment outcome
Leukemia, chronic myeloid
Myeloid leukemia
Patient compliance
Hematology
lcsh:Diseases of the blood and blood-forming organs
Therapeutics
Review article
Internal medicine
hemic and lymphatic diseases
Immunology
medicine
Adverse effect
business
Bcr-Abl Tyrosine Kinase
Tyrosine kinase
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Journal :
- Revista Brasileira de Hematologia e Hemoterapia v.36 n.1 2014, Revista brasileira de hematologia e hemoterapia, Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular (ABHHTC), instacron:ABHHTC, Revista Brasileira de Hematologia e Hemoterapia, Vol 36, Iss 1, Pp 54-59 (2014), Revista Brasileira de Hematologia e Hemoterapia, Revista Brasileira de Hematologia e Hemoterapia, Volume: 36, Issue: 1, Pages: 54-59, Published: JAN 2014
- Accession number :
- edsair.doi.dedup.....0152b309ea51c745e50ef5947194a84e